Exchange Traded Concepts LLC Sells 2,635 Shares of CME Group Inc. (NASDAQ:CME)

Exchange Traded Concepts LLC lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 19.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,644 shares of the financial services provider’s stock after selling 2,635 shares during the period. Exchange Traded Concepts LLC’s holdings in CME Group were worth $2,349,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Capital International Investors grew its holdings in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. lifted its position in CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. M&G Plc purchased a new position in CME Group in the 1st quarter worth approximately $156,631,000. Assenagon Asset Management S.A. increased its holdings in shares of CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after buying an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CME shares. JPMorgan Chase & Co. increased their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Barclays raised their price objective on CME Group from $209.00 to $219.00 and gave the company an “equal weight” rating in a report on Monday, October 7th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a research note on Thursday, October 3rd. Piper Sandler lifted their price target on shares of CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. Finally, The Goldman Sachs Group upped their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $219.53.

CME Group Price Performance

Shares of CME stock opened at $224.20 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $80.73 billion, a P/E ratio of 25.51, a P/E/G ratio of 7.76 and a beta of 0.55. The business’s 50 day moving average price is $215.15 and its 200-day moving average price is $207.94. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $226.78.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the previous year, the firm earned $2.30 EPS. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, equities research analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.05%. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.